<DOC>
	<DOCNO>NCT02506257</DOCNO>
	<brief_summary>Randomized , double-masked , placebo-controlled , multiple center , parallel-group Phase 1 study evaluate safety tolerability 3 dose preservative-free PHMB ophthalmic solution compare placebo healthy subject</brief_summary>
	<brief_title>Safety Tolerability Preservative-free Polyhexamethylene Biguanide ( PHMB ) Ophthalmic Solution Healthy Subjects</brief_title>
	<detailed_description>The primary objective study establish ocular safety tolerability , systemic safety 3 different concentration preservative-free PHMB healthy subject . Safety tolerability compare placebo.The PHMB bioavailability plasma also assess</detailed_description>
	<mesh_term>Keratitis</mesh_term>
	<mesh_term>Acanthamoeba Keratitis</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Polyhexamethylene biguanide</mesh_term>
	<criteria>able willing give inform consent . man woman race 18 55 year age , inclusive . Body Mass Index 2030 kg/m2 willing able attend require study visit . bilateral visual acuity &gt; 6/10 . intraocular pressure ( IOP ) 1421 mmHg . ophthalmologic examination without abnormality . medical history without major pathology . laboratory test result without deviation normal range . female subject childbearing potential negative urine pregnancy test use effective contraception study . presence bacterial ocular infection . presence concomitant ocular pathology . performing activity likely result irritate conjunctiva study ( include heavy alcohol intake , swim chlorinated water heavy smoking ) . contact lenses wear . ocular surface fluorescein stain score &gt; 3 . use topical systemic antibiotic , antihistamine , decongestant nonsteroidal antiinflammatory agent well steroid within 7 day screen . know suspected allergy biguanides intolerance ingredient test treatment . ocular surgery perform within 12 month screen . participation another clinical study precede 30 day . one functional eye . pregnancy breastfeed . use recreational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>